Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - concentrated antigens of dichelobacter nodosus; light liquid paraffin; thiomersal - misc. vaccines or anti sera - concentrated antigens of dichelobacter nodosus vaccine-antigen/antibody active 100.0 ug/ml; light liquid paraffin ungrouped other 600.0 ul/ml; thiomersal mercury other 0.05 mg/ml - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - footrot - dichelobacter nodosus

Moldova - rumensk - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

schering-plough central east ag - sitagliptinum - comprimate filmate - 100 mg

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - n-methyl-2-pyrrolidone; diflubenzuron - topical solution/suspension - n-methyl-2-pyrrolidone solvent active 300.0 g/l; diflubenzuron uron active 20.0 g/l - parasiticides - cattle | lamb unshorn - up to 3 months old | sheep - up to 7 days off-shears | beef | bos indicus | bos taurus | bovine | buffal - cattle biting louse | sheep body louse | shortnosed cattle louse | sucking lice - linognathus vituli | tubercle-bearing louse | cattlebiting louse | damalinia bovis (old name) | damalinia ovis (prev. genus) | lice - synthetic pyrethroid re | little blue sucking louse | sheep body lice | short nosed sucking louse

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - florfenicol - parenteral liquid/solution/suspension - florfenicol antibiotic active 300.0 mg/ml - antibiotic & related - cattle | pigs | beef | boar | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | gilt | hei - actinobacillus pleuropneumoniae (haemoph | bacterial infection | bovine respiratory disease | footrot - dichelobacter nodosus | fusobacterium necrophorum | haemophilus spp. | mycoplasma spp. | pasteurella multocida | pink-eye | streptococcus suis | swine dysentery | amoxycillin sensitive bacteria | associated with viral disease | fowl cholera | gram negative organisms | gram positive organisms | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | post parturient bacterial infe | primary bacterial infection | shipping fever | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - megestrol acetate - oral tablet - megestrol acetate steroid-progestin active 20.0 mg/tb - endocrine system - cat | dog | dog - female (bitch) | bitch | castrate | cat - queen | cat - tom | kitten | puppy - eosinophilic granulomas | improving behaviour | mammary tumours | miliary eczema | modify hypersexuality | postpone oestrus | prevent oestrus | pseudo-pregnancy | urine spray | eliminate urine spraying | excess libido - reduce | pseudo-cyesis | pseudo-pregnancy lactation

Australia - engelsk - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - megestrol acetate - oral tablet - megestrol acetate steroid-progestin active 5.0 mg/tb - endocrine system - cat | dog | dog - female (bitch) | bitch | castrate | cat - queen | cat - tom | kitten | puppy - eosinophilic granulomas | improving behaviour | mammary tumours | miliary eczema | modify hypersexuality | postpone oestrus | prevent oestrus | pseudo-pregnancy | urine spray | eliminate urine spraying | excess libido - reduce | pseudo-cyesis | pseudo-pregnancy lactation

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 250 mg - capsule, hard - excipient ingredients: sodium lauryl sulfate; lactose; stearic acid; gelatin; titanium dioxide; sodium starch glycollate; tartaric acid; colloidal anhydrous silica; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 100 mg - capsule, hard - excipient ingredients: tartaric acid; sodium lauryl sulfate; iron oxide red; lactose; colloidal anhydrous silica; stearic acid; gelatin; sodium starch glycollate; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 20 mg - capsule, hard - excipient ingredients: tartaric acid; colloidal anhydrous silica; iron oxide yellow; gelatin; lactose; sodium lauryl sulfate; stearic acid; titanium dioxide; sodium starch glycollate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide; simethicone - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - temozolomide, quantity: 5 mg - capsule, hard - excipient ingredients: indigo carmine; sodium lauryl sulfate; tartaric acid; iron oxide yellow; lactose; colloidal anhydrous silica; sodium starch glycollate; gelatin; stearic acid; titanium dioxide; propylene glycol; ethanol; butan-1-ol; purified water; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - temodal capsules are indicated for the treatment of patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as adjuvant treatment; recurrence of anaplastic astrocytoma and glioblastoma multiforme following standard therapy. temodal capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma.